Food For Thought On US FDA Reforms
Executive Summary
An independent review of the US FDA’s food regulatory programs could renew a debate over splitting FDA into two agencies. That could be a distraction for the agency in the coming year – but it could also help keep the medical product review groups out of the political hot seat.
You may also be interested in...
Pharma Remains In US FDA Back Seat As Food, Tobacco Priorities Take Center Stage
FDA Deputy Commissioner for Policy, Legislation and International Affairs Kimberlee Trzeciak has non-medical product work at top of her agenda, highlighting shift in attention that has been a mainstay of FDA commissioner Robert Califf's tenure.
Pharma Continues To Sit In Back Seat As Tobacco, Food Priorities Take Center Stage At FDA
New FDA Deputy Commissioner for Policy, Legislation and International Affairs Kimberlee Trzeciak has non-medical product work on the top of her agenda, highlighting the shift in attention that has been a mainstay of FDA commissioner Robert Califf's tenure.
US FDA Food Safety Overhaul Will Have Ripple Effects For Drug Inspections
A restructuring of FDA’s food safety operations includes changes to the agency-wide office that handles all inspections, including those of drug manufacturers. It’s another shift in the delicate balancing of centralized management of ORA with the specific needs and priorities of the different centers.